<?xml version="1.0" encoding="UTF-8"?>
<p>Biological profiling of compounds was undertaken using well-established protocols. Antiplasmodial activity was determined by testing compounds against chloroquine-sensitive (3D7) and chloroquine-resistant (Dd2) strains of 
 <italic>Plasmodium falciparum</italic> as previously comprehensively described by Duffy and Avery [
 <xref rid="B21-marinedrugs-19-00095" ref-type="bibr">21</xref>].
</p>
